ArticleWorld journal of surgical oncology2026
The HALP-CONUT integrated score predicts survival and postoperative complications in locally advanced esophageal squamous cell carcinoma following neoadjuvant therapy: evidence from a multicenter retrospective cohort study.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe prognostic role of nutrition-inflammation indices in esophageal squamous cell carcinoma (ESCC) requires further investigation. We developed the HALP-CONUT Integrated Score (HCIS) and evaluated its ability to predict survival and postoperative complications in locally advanced ESCC patients undergoing neoadjuvant therapy.
methodsThis multicenter retrospective study analyzed 410 patients. HCIS was calculated by integrating the HALP index and CONUT score. Patients were stratified into risk groups. Survival was analyzed using Kaplan-Meier and Cox regression. Logistic regression assessed associations with complications and pathologic complete response (pCR). Predictive performance was evaluated using ROC curves, C-index, and decision curve analysis.
resultsPatients with high HCIS scores had significantly worse overall survival (OS) compared with those in lower-risk groups (p < 0.001). Multivariate Cox analysis confirmed HCIS as an independent prognostic factor for OS (HR 4.59, 95% CI 2.64-7.97, p < 0.001). Higher HCIS scores were also independently associated with increased risk of major postoperative complications (OR 7.144, 95% CI 3.698-13.813, p < 0.001) and a lower likelihood of achieving pCR (OR 6.470, 95% CI 3.577-12.40, p = 0.005). Predictive models incorporating HCIS demonstrated superior discrimination compared with models based on HALP or CONUT alone (AUC for OS: 0.789 vs 0.711 and 0.703, respectively).
conclusionHCIS is a robust biomarker that integrates hematologic, nutritional, and inflammatory parameters. It independently predicts survival, postoperative complications, and pCR, providing a valuable tool for risk stratification and individualized treatment planning in locally advanced ESCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.